FLAVIA LOPEZ: Open Payments
NPI 1063072700 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,434 in 73 payments from 13 companies in 2025. Trend: 2023 $1,757 · 2024 $2,214 · 2025 $1,434
Food & beverage: $1,434
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 21 | $459 |
| Novo Nordisk Inc | 21 | $298 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $174 |
| Amgen Inc. | 12 | $149 |
| Verona Pharma, Inc. | 1 | $117 |
| Xeris Pharmaceuticals, Inc. | 2 | $44 |
| Corcept Therapeutics | 2 | $37 |
| Dexcom, Inc. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| PFIZER INC. | 2 | $34 |
Products named: Ozempic, MOUNJARO, KISUNLA, Ohtuvayre, OTEZLA, ZEPBOUND, JARDIANCE, RECORLEV.
Industry payments across TX — which companies pay providers there.
